News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
257,731 Results
Type
Article (36912)
Company Profile (18)
Press Release (220801)
Section
Business (71492)
Career Advice (456)
Deals (7153)
Drug Delivery (12)
Drug Development (32191)
Employer Resources (39)
FDA (6517)
Job Trends (5091)
News (116428)
Policy (8580)
Tag
2024 Biotech Bay Standard (2)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
Academia (2604)
Academic (1)
Accelerated approval (1)
Adcomms (7)
Allergies (27)
Alliances (17287)
ALS (35)
Alzheimer's disease (600)
Antibody-drug conjugate (ADC) (18)
Approvals (6541)
Artificial intelligence (68)
Autoimmune disease (2)
Automation (4)
Bankruptcy (41)
Best Places to Work (4398)
BIOSECURE Act (3)
Biosimilars (16)
Biotechnology (15)
Bladder cancer (20)
Brain cancer (8)
Breast cancer (93)
Cancer (696)
Cardiovascular disease (79)
Career advice (421)
Career pathing (9)
CAR-T (46)
Cell therapy (131)
Cervical cancer (6)
Clinical research (25340)
Collaboration (199)
Compensation (7)
Complete response letters (2)
COVID-19 (1820)
CRISPR (13)
C-suite (137)
Cystic fibrosis (30)
Data (863)
Decentralized trials (1)
Denatured (3)
Depression (11)
Diabetes (75)
Diagnostics (2785)
Digital health (6)
Diversity (5)
Diversity, equity & inclusion (14)
Drug discovery (24)
Drug pricing (19)
Drug shortages (2)
Duchenne muscular dystrophy (24)
Earnings (14519)
Editorial (4)
Employer branding (3)
Employer resources (36)
Events (26654)
Executive appointments (442)
FDA (6889)
Featured Employer (6)
Frontotemporal dementia (4)
Funding (239)
Gene editing (38)
Generative AI (6)
Gene therapy (97)
GLP-1 (171)
Government (1817)
Guidances (10)
Healthcare (9001)
Huntington's disease (4)
IgA nephropathy (5)
Immunology and inflammation (16)
Indications (9)
Infectious disease (1885)
Inflammatory bowel disease (51)
Inflation Reduction Act (2)
Influenza (25)
Intellectual property (16)
Interviews (46)
IPO (3044)
IRA (7)
Job creations (810)
Job search strategy (395)
Kidney cancer (4)
Labor market (5)
Layoffs (54)
Leadership (2)
Legal (1349)
Liver cancer (27)
Lung cancer (98)
Lymphoma (52)
Machine learning (1)
Management (12)
Manufacturing (49)
MASH (22)
Medical device (6044)
Medtech (6045)
Mergers & acquisitions (4195)
Metabolic disorders (156)
Multiple sclerosis (25)
NASH (5)
Neurodegenerative disease (26)
Neuropsychiatric disorders (1)
Neuroscience (746)
NextGen: Class of 2025 (3042)
Non-profit (2544)
Northern California (720)
Now hiring (3)
Obesity (60)
Opinion (41)
Ovarian cancer (32)
Pain (17)
Pancreatic cancer (26)
Parkinson's disease (34)
Partnered (3)
Patents (44)
Patient recruitment (47)
Peanut (18)
People (35240)
Pharmaceutical (2)
Pharmacy benefit managers (1)
Phase I (7558)
Phase II (11332)
Phase III (8425)
Pipeline (263)
Podcasts (4)
Policy (20)
Postmarket research (1369)
Preclinical (3512)
Press Release (26)
Prostate cancer (29)
Psychedelics (8)
Radiopharmaceuticals (87)
Rare diseases (113)
Real estate (1844)
Recruiting (17)
Regulatory (6090)
Reports (8)
Research institute (1663)
Resumes & cover letters (33)
Rett syndrome (2)
RNA editing (1)
RSV (22)
Schizophrenia (13)
Series A (36)
Series B (25)
Service/supplier (1)
Sickle cell disease (26)
Southern California (571)
Spinal muscular atrophy (54)
Sponsored (8)
Startups (1420)
Stomach cancer (2)
Supply chain (6)
United States (6362)
Vaccines (334)
Venture capitalists (1)
Webinars (9)
Weight loss (30)
Women's health (6)
Worklife (3)
Date
Today (69)
Last 7 days (225)
Last 30 days (836)
Last 365 days (10384)
2025 (2316)
2024 (10873)
2023 (13416)
2022 (20714)
2021 (22397)
2020 (22092)
2019 (19114)
2018 (14255)
2017 (12406)
2016 (12472)
2015 (14218)
2014 (10765)
2013 (10222)
2012 (10457)
2011 (10701)
2010 (9573)
Location
Africa (344)
Alabama (15)
Alaska (3)
Arizona (68)
Arkansas (9)
Asia (15529)
Australia (3281)
California (1540)
Canada (534)
China (133)
Colorado (91)
Connecticut (76)
Delaware (39)
Europe (37429)
Florida (281)
Georgia (72)
Idaho (20)
Illinois (211)
India (7)
Indiana (88)
Iowa (2)
Japan (50)
Kansas (23)
Kentucky (13)
Louisiana (3)
Maine (16)
Maryland (220)
Massachusetts (1040)
Michigan (53)
Minnesota (112)
Mississippi (1)
Missouri (28)
Montana (16)
Nebraska (7)
Nevada (16)
New Hampshire (22)
New Jersey (537)
New Mexico (16)
New York (475)
North Carolina (395)
North Dakota (3)
Northern California (720)
Ohio (79)
Oklahoma (5)
Oregon (11)
Pennsylvania (348)
Puerto Rico (1)
Rhode Island (9)
South America (445)
South Carolina (10)
Southern California (571)
Tennessee (62)
Texas (258)
Utah (52)
Virginia (45)
Washington D.C. (18)
Washington State (153)
West Virginia (2)
Wisconsin (12)
257,731 Results for "uppsala university hospital".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Uppsala University Hospital and Sana Biotechnology Announce Authorization of the First-in-Human Clinical Trial Application for a Primary Islet Cell Treatment for Patients with Type 1 Diabetes
Sana Biotechnology, Inc. and Uppsala University Hospital in Sweden today announced the Swedish Medical Products Agency has authorized Uppsala University’s Clinical Trial Application (CTA) to initiate an investigator-sponsored, first-in-human study of UP421, an allogeneic, primary islet cell therapy engineered with Sana’s hypoimmune (HIP) technology, in patients with type 1 diabetes.
November 17, 2023
·
7 min read
Genetown
MitoSense Inc. and Uppsala University, in Collaboration with Elliott Mitochondrial Center and Sallie Astor Burdine Breast Foundation, Announce Breakthrough in Mitochondrial Preservation
MitoSense Inc. in collaboration with Uppsala University, Elliott Mitochondrial Center, and the Sallie Astor Burdine Breast Foundation in Baton Rouge, Louisiana, USA, proudly announces a landmark scientific breakthrough in the field of mitochondrial preservation, a key element in mitochondrial transplantation therapies.
January 25, 2024
·
2 min read
Press Releases
University Medical Centre Ljubljana and University Hospital of Maribor Elevate Antimicrobial Stewardship with DoseMeRx
January 15, 2025
·
3 min read
Press Releases
Novotech Partners with Kyungpook National University Hospital to Strengthen Clinical Trial Capabilities in South Korea
March 19, 2025
·
4 min read
Press Releases
Quest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals
January 27, 2025
·
2 min read
Press Releases
Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital
February 24, 2025
·
5 min read
BioMidwest
Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care
Accuray Incorporated announced that long-term customer Heidelberg University Hospital in Heidelberg, Germany, has selected the company’s Radixact® System, equipped with its proprietary ClearRT®, Synchrony® and VOLO™ Ultra Optimizer solutions, to help transform their approach to cancer care.
June 27, 2024
·
5 min read
Business
Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases
Evotec SE announced that the Company entered a partnership with Inserm, the French National Institute of Health and Medical Research, Lille University Hospital and Inserm Transfert to identify novel therapeutic targets and diagnostic and prognostic markers in obesity and metabolic diseases.
May 30, 2024
·
11 min read
Bio NC
Asensus Surgical Announces St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan to Initiate Senhance Surgery Program
Asensus Surgical, Inc. announced that St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan has entered into an agreement to lease and utilize a Senhance® Surgical System in the Urology and Gastroenterology/General Surgery department.
June 24, 2024
·
5 min read
Press Releases
Seoul National University Bundang Hospital Establishes the first “International PSP Research and Treatment Center” in Korea
December 9, 2024
·
8 min read
1 of 25,774
Next